Cas:1616760-97-4 Tofacitinib Impurity 2 manufacturer & supplier

Chemical Name:Tofacitinib Impurity 2

CAS.NO:1616760-97-4

Synonyms:7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 2-chloro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-;2-Chloro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine

Molecular Formula:C₁₃H₁₈ClN₅

Molecular Weight:279.768

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.3±0.1 g/cm3

Index of Refraction:1.643

PSA:

Exact Mass:279.125061

LogP:2.81

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 2-chloro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]- chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-Chloro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,7H-Pyrrolo[2,3-d]pyrimidin-4-amine, 2-chloro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]- Use and application,2-Chloro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine technical grade,usp/ep/jp grade.

Related News: Researchers engineered IgM antibodies and found that in all cases, these antibodies were significantly more potent than standard IgG antibodies in neutralizing the COVID-19 virus. 3,8-Diazabicyclo[3.2.1]octane, 3-(2-naphthalenyl)- manufacturers “Alcami supported this product with supply constraints and successfully developed a capsule formulation for two dosage strengths,” she explains. “The formulations group performed studies at a micro-laboratory scale using a scientifically-based approach to identify a lead prototype. Triacontane, 1,1′-oxybis- suppliers Officials did, however, acknowledge that there’s growing evidence an extra jab may enhance the antibody response in immunocompromised people. Some small studies suggest up to 50% of people with no antibody response after the authorized regimen of two mRNA jabs developed a response after an additional dose, said CDC’s Sara Oliver, M.D. (2-Methyl-4-(N.N-bis-(2-iod-aethyl)-amino)-benzylidenamino)-cyclopentan vendor & factory.